- Written by Editor-in-Chief
- Category: Industry News
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials. Following types of plate rich plasma (PRP) preparations are currently available in the market:
- Leukocyte-poor or pure PRP
- Leukocyte PRP
- Pure platelet-rich fibrin clot
- Leukocyte platelet-rich fibrin clot
In spite of non-regulatory approval, PRP has been widely used in sports medicine.
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!